drug control

Q&A: HISA's Anti-Doping and Medication Control Program

The Horseracing Integrity and Safety Act's (HISA) drug control program has encountered some choppy waters since its launch on May 22, encapsulated by events surrounding the law's rules on intra-articular joint injections. At the end of last month, HISA CEO Lisa Lazarus explained that the Authority--the non-profit umbrella broadly overseeing implementation of the federal law--had temporarily suspended full enforcement of its rules surrounding intra-articular joint injections prior to workouts. Under HISA's rules as written, trainers are prohibited from giving their horse intra-articular joint injections within 14 days prior to the...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.